Back to Search

KYMR

Kymera Therapeutics, Inc. Common Stock
Data: 2026-08-21
$119.8
Price
-1.40%
Change
$130.05
52W High
$39.84
52W Low
Full AI Analysis Buy/Sell Forecast Trendline Why Moving Charts Options

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.

Quick Stats
Aug 21, 2026

38.3

AI Score

EXTENDED

0.78

Volume Ratio

TBA

Next Earnings

18

+ve Days (30d)

12

-ve Days (30d)

KYMR Stock Summary

Last updated Aug 21, 2026

KYMR is currently trading at $119.8, positioned above its 200-day moving average of $86.18, indicating a long-term uptrend. The stock has a 52-week range of $39.84 to $130.05.

Technical Analysis: The 50-day moving average stands at $108.73, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 60.2, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.246, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates KYMR at 38.3/100 with a EXTENDED recommendation.

KYMR (Kymera Therapeutics, Inc. Common Stock) Indicators

Last updated Aug 21, 2026

Indicator Value
RSI(14) 60.2
CMF (20) 0.246
ROC (10) 11.421
ADX (14) 34.874
Indicator Value
MACD (12,26,9) 4.223
AROONOSC (14) 85.714
WILLAMS %R (14) -28.177
MFI (14) 83.751
KYMR Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

KYMR Price vs Max Options Open Interest
KYMR Max Change In Options Open Interest

KYMR Options - Sort by Max open Interest (near term)

23rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

KYMR Daily Out of Money Options - Sort by Max open Interest (near term)

23rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

KYMR Daily In the Money Options - Sort by Max open Interest (near term)

23rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

KYMR Most Active Options by Volume(near term)

23rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI		 Ask PC Delta Vega Volatility % change Track

Kymera Therapeutics, Inc. Common Stock is above both the 50 Day and 200 Day SMA which is considered Bullish.

KYMR Moving Averages Analysis

Kymera Therapeutics, Inc. Common Stock has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Aug 21, 2026

Kymera Therapeutics, Inc. Common Stock has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Aug 21, 2026

KYMR (Kymera Therapeutics, Inc. Common Stock) Simple Moving Averages

Moving Averages are last updated Aug 21, 2026

Days MA
10 117.54
20 111.57
30 111.78
50 108.73
100 95.78
200 86.18

KYMR Fundamental Analysis

P/E (Forward) --
P/E (Trailing) --
Market Cap ($) 10.1 billion
Earnings/Share ($) -3.1
Net Profit Margin (%) -2.8533
Dividend/Share ($) --
EPS Estimate Current Year ($) -3.7982
EPS Estimate Next Year ($) -4.9591
WallStreet Target Price ($) 130.91
Most Recent Quarter